Condition
Cerebral Venous Thrombosis clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Cerebral Venous Thrombosis clinical trials that are recruiting, at sites in 3 countries (most in China (3), Vietnam (2), Netherlands (1)). 1 was first registered in the last 30 days. By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 3Countries
Newest Cerebral Venous Thrombosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Danang Cerebral Venous Thrombosis Registry | — | Da Nang, Da Nang | Recruiting | Oct 22, 2026 |
| Anticoagulation Plus Tocilizumab for Acute Cerebral Venous Thrombosis | — | Beijing, Beijing Municipality | Recruiting | Sep 3, 2026 |
| Anticoagulation plus batroxobin for acute cerebral venous thrombosis | Phase 4 | Beijing, Beijing Municipality | Recruiting | Jan 20, 2026 |
| DOAC treatment outcomes for cerebral venous thrombosis in Vietnam | — | Hanoi, Hanoi | Recruiting | Jul 24, 2025 |
| Evaluating the safety and effectiveness of edoxaban and rivaroxaban for treating cerebral venous thrombosis in Chinese patients | — | Beijing, Beijing Municipality | Recruiting | Apr 27, 2025 |
| Using direct oral anticoagulants to treat cerebral venous thrombosis | — | Amsterdam, North Holland | Recruiting | Dec 9, 2020 |
All recruiting trials (6)
-
Danang Cerebral Venous Thrombosis Registry
This registry collects information on adults with cerebral venous thrombosis admitted to Danang Hospital to see how the condition presents, what imaging shows, risk factors, and how patients recover.
-
Anticoagulation Plus Tocilizumab for Acute Cerebral Venous Thrombosis
This study tests whether adding a single dose of tocilizumab to standard blood thinners helps people with acute cerebral venous thrombosis.
-
Anticoagulation plus batroxobin for acute cerebral venous thrombosis
This trial tests whether adding batroxobin to standard anticoagulation helps adults with acute cerebral venous thrombosis.
-
DOAC treatment outcomes for cerebral venous thrombosis in Vietnam
This project will try direct oral anticoagulants (dabigatran or rivaroxaban) in adults with cerebral venous thrombosis to see if they are safe and effective in routine care.
-
Evaluating the safety and effectiveness of edoxaban and rivaroxaban for treating cerebral venous thrombosis in Chinese patients
This study is testing whether two blood thinners, edoxaban and rivaroxaban, are safe and effective for treating cerebral venous thrombosis in Chinese patients aged 18 to 80.
-
Using direct oral anticoagulants to treat cerebral venous thrombosis
This study is testing whether a new type of blood thinner called direct oral anticoagulants can safely and effectively treat people with cerebral venous thrombosis.
Related topics
Quick answers
How many Cerebral Venous Thrombosis clinical trials are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), Vietnam (2 trials), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.